10Sep 2017


  • M.B.B.S, Family Medicine Resident.
  • Family Medicine Consultant.
  • Family & Community Medicine Consultant.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Objectives: To estimates the level of knowledge of cervical cancer, cervical screening and to identify their determinants among MOH PHC physicians in Makkah Al-Mokarramah city 2016. Subjects and methods: A cross-sectional study was done among physicians working at Ministry of health primary health care centers, Makkah AL-Mokarramah A validated self-created self-administered questionnaire was used for data collection including (socio-demographic and physicians? knowledge about cervical cancer and its screening guidelines). Results: The study included 137 physicians, with a mean age 39.7 ? 8.8 years. Almost half of participants (46.7%) were males, 43.1% were Saudi, 36.5% of PHCCs were JCI/CBAHI-accredited. Most participants (89.1%) heard about Pap smear testing, while only 36.5% had an MOH-protocol for cervical cancer screening, 33.6% ask asymptomatic female patients about screening for cancer cervix, 14.6% always refer female patients for screening for cancer cervix, 49.6% read about cervical screening guidelines last year, 26.3% attended CME on cervical cancer and its screening last year. The most frequent correctly answered statements by PHC physicians about cancer cervix were related to cervical cancer is preventable (78.8%) and history of sexually transmitted infections as a high-risk factor for cervical cancer (73.7%). Overall, 31.4% of the physicians were knowledgeable regarding cancer cervix and its screening guidelines. Conclusion: The overall knowledge of PHC physicians working at MOH inside Makkah AL-Mokarramah was suboptimal regarding cervical cancer and its screening guidelines. PHC physicians should be encouraged toward regularly attending CME courses/workshops on prevention and management of cancer cervix.

  1. GLOBOCAN Cancer Fact Sheets: Cervical cancer [Internet]. [cited 2016 Jan 8]. Available from: http://globocan.iarc.fr/old/FactSheets/cancers/cervix-new.asp
  2. Council HS. Saudi Cancer Registry. 2010 [Internet]. 2010;24?6. Available from: http://www.chs.gov.sa/Ar/mediacenter/NewsLetter/2010 Report (1).pdf
  3. Walboomers JM, Jacobs M V, Manos MM, Bosch FX, Kummer JA, Shah K V, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol [Internet]. 1999 Sep [cited 2015 Jan 11];189(1):12?9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10451482
  4. Turki R, Sait K, Anfinan N, Sohrab SS, Abuzenadah AM. Prevalence of human papillomavirus in women from Saudi Arabia. Asian Pac J Cancer Prev [Internet]. 2013 Jan [cited 2016 Jan 7];14(5):3177?81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23803100
  5. AlObaid A, Al-Badawi IA, Al-Kadri H, Gopala K, Kandeil W, Quint W, et al. Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia. BMC Infect Dis [Internet]. 2014 Jan 14 [cited 2015 Dec 13];14(1):643. Available from: http://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-014-0643-8
  6. Alsbeih G, Ahmed R, Al-Harbi N, Venturina LA, Tulbah A, Balaraj K. Prevalence and genotypes? distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia. Gynecol Oncol [Internet]. 2011 Jun 1 [cited 2016 Jan 8];121(3):522?6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21353296
  7. Society of Gynecologic Oncologists Education Resource Panel Writing group C, Collins Y, Einstein MH, Gostout BS, Herzog TJ, Massad LS, et al. Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists. Gynecol Oncol [Internet]. 2006 Sep [cited 2017 Mar 4];102(3):552?62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16979432
  8. Berrington De Gonz?lez A, Green J. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer [Internet]. 2007 Feb 15 [cited 2017 Apr 18];120(4):885?91. Available from: http://doi.wiley.com/10.1002/ijc.22357
  9. Appleby P, Beral V, Berrington De Gonz?lez A, Colin D, Franceschi S, Goodill A, et al. Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer [Internet]. 2006 Mar 15 [cited 2017 Apr 18];118(6):1481?95. Available from: http://doi.wiley.com/10.1002/ijc.21493
  10. International Collaboration of Epidemiological Studies of Cervical Cancer B, Appleby P, Beral V, Berrington de Gonz?lez A, Colin D, Franceschi S, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet (London, England) [Internet]. 2007 Nov 10 [cited 2017 Mar 4];370(9599):1609?21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17993361
  11. Li N, Franceschi S, Howell-Jones R, Snijders PJF, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer [Internet]. 2011 Feb 15 [cited 2017 Mar 4];128(4):927?35. Available from: http://doi.wiley.com/10.1002/ijc.25396
  12. Mutter G, Prat J. Pathology of the Female Reproductive Tract [Internet]. Churchill Livingstone/Elsevier; 2014 [cited 2017 Apr 18]. 1066 p. Available from: https://books.google.com.sa/books?id=ab545XL-MBEC&pg=PA219&dq=Cervical+cancer+usually+originate+at+transformation+zone&hl=en&sa=X&redir_esc=y#v=onepage&q=Cervical cancer usually originate at transformation zone&f=false
  13. DiSaia PJ CW. Clinical Gynecologic Oncology, 7th ed. 7th ed. Philadelphia: Mosby Elsevier; 2007. p. 55.
  14. Chang AE, Hayes DF, Pass HI, Stone RM, Ganz PA, Kinsella TJ, et al. Oncology: An evidence-based approach. Oncol An Evidence-Based Approach [Internet]. 2006 [cited 2017 Apr 17];(January):1?2005. Available from: https://books.google.com.sa/books?id=vxh6u1-ETk0C&pg=PA875&dq=physical+examination+in+cervical+cancer&hl=en&sa=X&redir_esc=y#v=onepage&q=physical examination in cervical cancer&f=false
  15. Partridge EE, Abu-Rustum NR, Campos SM, Fahey PJ, Farmer M, Garcia RL, et al. Cervical Cancer Screening. J Natl Compr Cancer Netw [Internet]. 2010 Dec [cited 2017 Apr 17];8(12):1358?86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21147902
  16. Pecorelli S. FIGO COMMITTEE ON GYNECOLOGIC ONCOLOGY Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet [Internet]. [cited 2017 Mar 5];105:103?4. Available from: http://www.csh.org.tw/dr.tcj/Educartion/Cancer center/PDF/2010/FIGO staging revision 2009.pdf
  17. TNM A. cervical cancer staging TNM. [cited 2017 Mar 5]; Available from: https://cancerstaging.org/references-tools/quickreferences/Documents/CervixMedium.pdf
  18. Greer BE, Koh W-J, Abu-Rustum NR, Apte SM, Campos SM, Chan J, et al. Cervical cancer. J Natl Compr Canc Netw [Internet]. 2010 Dec [cited 2017 Apr 18];8(12):1388?416. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21147903
  19. World Health Organisation. Comprehensive Cervical Cancer Control [Internet]. WHO Library Cataloguing-in-Publication Data. 2014. Available from: http://apps.who.int/iris/bitstream/10665/144785/1/9789241548953_eng.pdf
  20. Final Recommendation Statement: Cervical Cancer: Screening - US Preventive Services Task Force [Internet]. [cited 2016 Jan 8]. Available from: http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/cervical-cancer-screening
  21. Profile on: George Papanikolaou, creator of the cervical Pap smear?test | To Muse and Carouse on WordPress.com [Internet]. [cited 2016 Jan 8]. Available from: http://solangefrancois.com/2012/03/04/profile-on-george-papanikolaou-creator-of-the-cervical-pap-smear-test/
  22. Committee on Practice Bulletins?Gynecology. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. Obstet Gynecol [Internet]. 2016 Oct [cited 2017 Mar 7];128(4):e111-30. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006250-201610000-00058
  23. Castle PE, Katki HA. Benefits and risks of HPV testing in cervical cancer screening. Lancet Oncol [Internet]. 2010 Mar [cited 2016 Jan 8];11(3):214?5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20089448
  24. Mayrand M-H, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer. N Engl J Med [Internet]. 2007 Oct 18 [cited 2017 Apr 17];357(16):1579?88. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa071430
  25. Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ [Internet]. 2009 Jan [cited 2016 Jan 8];339:b2968. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2718082&tool=pmcentrez&rendertype=abstract
  26. Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ [Internet]. 1999 Apr 3 [cited 2016 Jan 8];318(7188):904?8. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27810&tool=pmcentrez&rendertype=abstract
  27. Cervical Cancer Screening Guidelines for Average-Risk Women. [cited 2017 Jun 20]; Available from: https://www.cdc.gov/cancer/cervical/pdf/guidelines.pdf
  28. Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, Ferris DG, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin [Internet]. 2007 Jan 1 [cited 2017 Mar 8];57(1):7?28. Available from: http://doi.wiley.com/10.3322/canjclin.57.1.7
  29. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin [Internet]. 2012 [cited 2017 Mar 8];62(3):147?72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22422631
  30. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med [Internet]. 2007 May 10 [cited 2016 Jan 9];356(19):1915?27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17494925
  31. Huseyin Can1,2*, Ozgur Erdem3, Coskun Oztekin4, Sercan Bulut Celik4, Mete Onde5, Tahsin Celepkolu6, Kurtulus Ongel1 7. Are Primary Health Care Workers Aware of Cervical Cancer Risk? Asian Pacific J Cancer Prev Asian Pac J Cancer Prev. 2014;15(1516):6669?71.
  32. OBEIDAT BR, AMARIN ZO, ALZAGHAL L. Awareness, practice and attitude to cervical Papanicolaou smear among female health care workers in Jordan. Eur J Cancer Care (Engl) [Internet]. 2012 May [cited 2017 Jan 7];21(3):372?6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22050559
  33. del Refugio Gonzalez-Losa M, Gongora-Marfil GK, Puerto-Solis M. Knowledge about cervical cancer screening among family physicians: cross-sectional survey. J Eval Clin Pract [Internet]. 2009 Apr [cited 2017 Jan 13];15(2):289?91. Available from: http://doi.wiley.com/10.1111/j.1365-2753.2008.00996.x
  34. Holland-Barkis P, Forjuoh SN, Couchman GR, Capen C, Rascoe TG, Reis MD. Primary care physicians? awareness and adherence to cervical cancer screening guidelines in Texas. Prev Med (Baltim). 2006;42(2):140?5.
  35. Sait KH. Knowledge, attitudes, and practices regarding cervical cancer screening among physicians in the Western Region of Saudi Arabia. [Internet]. Vol. 32, Saudi Medical Journal. 2011 [cited 2016 Jan 8]. p. 1155?60. Available from: http://www.smj.org.sa/index.php/smj/article/view/7307
  36. Hyacinth HI, Adekeye OA, Ibeh JN, Osoba T. Cervical Cancer and Pap Smear Awareness and Utilization of Pap Smear Test among Federal Civil Servants in North Central Nigeria. PLoS One. 2012;7(10):1?8.
  37. Amal Alali (1), Dr. Mohamed Salem. Knowledge, attitudes and practices regarding cervical cancer screening among Female health care workers in primary healthcare in Qatar. MIDDLE EAST J Fam Med [Internet]. [cited 2016 Dec 30];VOLUME 14(8). Available from: http://www.mejfm.com/Ocober 2016/Cervical cancer.pdf
  38. World Health Organization. Comprehensive Cervical Cancer Control. A guide to essential practice. WHO Libr Cat Data [Internet]. 2006 [cited 2017 Apr 18];1?284. Available from: https://books.google.com.sa/books?id=a4cYeKpbXH8C&printsec=frontcover&dq=treatment+of+cervical+cancer&hl=en&sa=X&redir_esc=y#v=onepage&q=treatment of cervical cancer&f=false
  39. Mutyaba T, Mmiro FA, Weiderpass E. Knowledge, attitudes and practices on cervical cancer screening among the medical workers of Mulago Hospital, Uganda. BMC Med Educ [Internet]. 2006 Mar 1 [cited 2017 Jun 17];6(1):13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16509979
  40. Bose M, Titilope A, Andrew S, Titilayo O, Ololade O, Jonathan D. ―Cancer of the cervix and Cervical screening: current knowledge, attitude and practice of primary health care workers in Ikenne Local Government Area Ogun State, Nigeria. " IOSR J Nurs Heal Sci [Internet]. [cited 2017 Jan 6];5(5):2320?1940. Available from: www.iosrjournals.org
  41. Jhala D, Eltoum I. Barriers to adoption of recent technology in cervical screening. Cytojournal [Internet]. 2007 Aug 16 [cited 2017 Jun 17];4(1):16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17705820
  42. Riddell L, Swalwell-franks A. Screening for Cancer of the Cervix An Office Manual for Health Professionals. 2010; Available from: www.screeningbc.ca/cervix
  43. Lim JNW, Ojo AA. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review. Eur J Cancer Care (Engl) [Internet]. 2017 Jan 1 [cited 2017 Jun 19];26(1):e12444. Available from: http://doi.wiley.com/10.1111/ecc.12444
  44. Mutyaba T, Faxelid E, Mirembe F, Weiderpass E. Influences on uptake of reproductive health services in Nsangi community of Uganda and their implications for cervical cancer screening. Reprod Health [Internet]. 2007 [cited 2017 Jun 17];4(1):4. Available from: http://www.reproductive-health-journal.com/content/4/1/4
  45. Paz-Sold?n VA, Bayer AM, Nussbaum L, Cabrera L. Structural barriers to screening for and treatment of cervical cancer in Peru. Reprod Health Matters [Internet]. 2012 Dec [cited 2017 Jun 17];20(40):49?58. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23245408
  46. Roland KB, Larkins TL, Benard VB, Berkowitz Z, Saraiya M. Content analysis of continuing medical education for cervical cancer screening. J Womens Health (Larchmt) [Internet]. 2010 Apr [cited 2017 Jun 17];19(4):651?7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20350199
  47. Lai KQ, Nguyen TT, Mock J, McPhee SJ, Doan HT, Pham TH. Increasing Vietnamese-American physicians? knowledge of cervical cancer and pap testing: Impact of continuing medical education programs. Ethn Dis. 2004;14(3 SUPPL. 1).


Shaima’a Al Ahmadi
MBBS, Family Medicine Resident


Article DOI: 10.21474/IJAR01/5313       DOI URL: http://dx.doi.org/10.21474/IJAR01/5313

Share this article